Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antithrombotic Drugs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Not applicableStudy completedNCT04001166
What this trial is testing

Pharmacogenomics of Antithrombotic Drugs -a Register Linkage Study With National Registries and Biobanks in Finland

Who this might be right for
Individuals With a Disease of Cardiovascular System
VTT Technical Research Centre of Finland 7,005
Not applicableNot Yet RecruitingNCT07278648
What this trial is testing

High-risk Antithrombotic Drugs at Discharge and Consultation for Hemorrhagic or Thromboembolic Events in the Emergency Department

Who this might be right for
Acute Disease
Consorci Sanitari de l'Alt Penedès i Garraf 150
Not applicableStudy completedNCT02481011
What this trial is testing

Risk of Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs

Who this might be right for
Intracranial HemorrhagesStroke
St. Olavs Hospital 22,111
Not applicableStudy completedNCT02447341
What this trial is testing

Profile and Antithrombotic Management of Patients With NVAF Attending Internal Medicine Departments in Spain (PERFILAR Study)

Who this might be right for
Anticoagulation, Blood Thinners , Atrial Fibrillation, Bleeding, Stroke
Bristol-Myers Squibb 987
Not applicableStudy completedNCT04932603
What this trial is testing

Multidisciplinary Team Approach to Prescribe Antithrombotic Therapy in Older People With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Assistance Publique - Hôpitaux de Paris 833
Not applicableStudy completedNCT03310801
What this trial is testing

LAAO With DAPT Versus Antithrombotic Therapy

Who this might be right for
Atrial FibrillationCoronary Artery Disease
Korea University Anam Hospital 480
Not applicableStudy completedNCT05706740
What this trial is testing

Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life

Who this might be right for
Terminal Cancer
Johannes Gutenberg University Mainz 467
Not applicableStudy completedNCT04976530
What this trial is testing

Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)

Who this might be right for
Hemorrhage, SurgicalBlood Loss, SurgicalBlood Loss, Postoperative+1 more
CytoSorbents, Inc 140
Testing effectiveness (Phase 2)Study completedNCT02565693
What this trial is testing

Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation

Who this might be right for
Cerebral HemorrhageAtrial Fibrillation
UMC Utrecht 101
Post-approval studies (Phase 4)Ended earlyNCT02606552
What this trial is testing

Safety and Efficacy of Left Atrial Appendage Closure Versus Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Drug-Eluting Stent Implantation Due to Complex Coronary Artery Disease

Who this might be right for
Atrial FibrillationCoronary Artery Disease
Yonsei University 9
Not applicableStudy completedNCT01174862
What this trial is testing

Aspirin Responsiveness and Outcome in Coronary Artery Bypass Graft (CABG) Surgery

Who this might be right for
Coronary Artery Bypass Graft Triple VesselMyocardial IschemiaThrombosis+1 more
University Hospital, Basel, Switzerland 304
Post-approval studies (Phase 4)Not Yet RecruitingNCT07496281
What this trial is testing

OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation

Who this might be right for
Atrial Fibrillation (AF)Coronary Artery DiseaseDrug-eluting Stent
Ewha Womans University Mokdong Hospital 2
Large-scale testing (Phase 3)Ended earlyNCT03192215
What this trial is testing

AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

Who this might be right for
Stroke
Columbia University 1,015